Humacyte Company
Humacyte is a clinical-stage biotechnology platform company developing universally implantable bioengineered human tissue at a commercial scale to improve the lives of patients and transform the practice of medicine.
Investors
Connections from
Founded Date:
01.01.2004
Total Funding:
$400 000 000
Employee Number:
101-250
Funding Status:
Private investment in public equity(PIPE)
Technology:
Specific disorder-related
Last Funding Type:
Reverse Merger
Investors Number:
9
Last Funding Date:
17.02.2021
Industry:
Longevity
Headquarters:
United States
Estimated Revenue:
$10-50 Mn